Most Read Articles
one year ago
Cannabinoid hyperemesis syndrome (CHS) should be regarded as an important differential diagnosis in recurrent nausea and vomiting, according to a retrospective cohort study .
Jackey Suen, one year ago
Several biomarker candidates may improve screening and monitoring of treatment response in colorectal cancer (CRC), inflammatory bowel disease (IBD) and hepatocellular carcinoma (HCC), say experts of the Department of Medicine and Therapeutics, Chinese University of Hong Kong (CUHK), at the CUHK’s Advances in Medicine 2015 conference.
one year ago
The Drug Control Authority (DCA) of Malaysia has approved a new indication for the long-acting somatostatin analogue lanreotide. This new indication is for the treatment of grade 1 and low grade 2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs)—of midgut, pancreatic or unknown origin except the hindgut—in adult patients with unresectable locally advanced or metastatic disease.
one year ago
In an exclusive interview with MIMS Doctor, renowned gastroenterologists from Subang Jaya Medical Centre, Dr Tan Soon Seng and Dr Ranjeev C K Prabhakeran,
shared their perspectives and experiences on the use of Fuse® (Full Spectrum Endoscopy) in their clinical practice. Both of them have been practicing gastroenterology
for almost 20 years and have completed more than 1,200 procedures using the Fuse® system.

Fuse® has been available in Malaysia since January 2015. Subang Jaya Medical Centre is the first medical centre in Asia and the ONLY one in Malaysia to use the
Fuse® at the present moment. As cited in The Lancet Oncology,1 March 2014, Fuse® Endoscopy System detected 69% more pre-cancerous polyps than standard forwardviewing colonoscopy.

Adolescents with chronic liver disease have higher rates of anxiety and depression

Roshini Claire Anthony
11 months ago

Young people who have undergone liver transplant (LT), or have autoimmune liver disease (AILD), or other chronic liver diseases have higher rates of depression and anxiety than the general adolescent population, according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2016 held in Athens, Greece.

To assess the prevalence of anxiety and depression in young people with LT, AILD, or chronic liver disease, 232 young people attending a liver transition clinic were given an electronically-administered questionnaire, 187 of whom participated in this study. [ESPGHAN 2016, abstract H-O-007]

Almost 18 percent of young people (mean age 18 years) attending the clinic reported having anxiety and depression, with 9.7 percent reporting probable major depressive disorder (MDD), and 2.2 percent having suicidal ideation. About 14 percent had probable anxiety disorder, with 5.4 percent having severe anxiety symptoms.

“These [findings] are higher than the estimated prevalence rates of anxiety or depression in the general adolescent population [about 6 percent],” said the study authors.

The most common reasons cited for distress were fatigue (42.3 percent), money problems (30.8 percent), worry (30.2 percent), problems at work or school (29.1 percent), low self-esteem (27.5 percent), and sleep difficulties (27.5 percent).

Items on the questionnaire pertained to concern and understanding of illness, impact of illness on life (consequences), how long the participants expected to have the illness (timeline), symptoms experienced (identity), and emotional effects of illness (emotional response). Participants were also asked if they thought treatment could help them with their condition (treatment control), and the amount of control they thought they had over their illness (personal control).

Elevated levels of depression and anxiety were significantly associated with higher perceived illness consequences, identity, concern, emotional response, and reduced perceptions of personal control, while there was no association between depression or anxiety and understanding of illness or treatment control.

The authors advocated for routine holistic care which included mental health screening and interventions for illness beliefs for this age group. 
Editor's Recommendations
Most Read Articles
one year ago
Cannabinoid hyperemesis syndrome (CHS) should be regarded as an important differential diagnosis in recurrent nausea and vomiting, according to a retrospective cohort study .
Jackey Suen, one year ago
Several biomarker candidates may improve screening and monitoring of treatment response in colorectal cancer (CRC), inflammatory bowel disease (IBD) and hepatocellular carcinoma (HCC), say experts of the Department of Medicine and Therapeutics, Chinese University of Hong Kong (CUHK), at the CUHK’s Advances in Medicine 2015 conference.
one year ago
The Drug Control Authority (DCA) of Malaysia has approved a new indication for the long-acting somatostatin analogue lanreotide. This new indication is for the treatment of grade 1 and low grade 2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs)—of midgut, pancreatic or unknown origin except the hindgut—in adult patients with unresectable locally advanced or metastatic disease.
one year ago
In an exclusive interview with MIMS Doctor, renowned gastroenterologists from Subang Jaya Medical Centre, Dr Tan Soon Seng and Dr Ranjeev C K Prabhakeran,
shared their perspectives and experiences on the use of Fuse® (Full Spectrum Endoscopy) in their clinical practice. Both of them have been practicing gastroenterology
for almost 20 years and have completed more than 1,200 procedures using the Fuse® system.

Fuse® has been available in Malaysia since January 2015. Subang Jaya Medical Centre is the first medical centre in Asia and the ONLY one in Malaysia to use the
Fuse® at the present moment. As cited in The Lancet Oncology,1 March 2014, Fuse® Endoscopy System detected 69% more pre-cancerous polyps than standard forwardviewing colonoscopy.